Proxima Bio, Inc. research brief
CIK 2104665
Generated Nov. 7, 2026, 2:48 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: NEW YORK NY. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- June 10, 2026 · D/A · 0002104665-26-000003 · Source evidence
Reported offering amount: 91454999 USD. Reported amount sold: 91454999 USD.
- Jan. 21, 2026 · D · 0002104665-26-000001 · Source evidence
Reported offering amount: 88500025 USD. Reported amount sold: 86264999 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Proxima Bio, Inc. research brief,” CIK 2104665, retrieved Nov. 7, 2026, 2:48 p.m.. Cite the specific accessions used. No amounts have been summed.